Retatrutide is an investigational triple incretin receptor agonist administered as a weekly subcutaneous injection in clinical trials, with dose escalation used to improve tolerability
A balanced diet, regular exercise, and sufficient sleep remain among the most important factors in preventing the development of overweight and obesity
By supporting the bodys internal detoxification processes, glutathione helps rejuvenate the skin from within
An elevated resting heart rate can increase long-term cardiovascular risk, and regulators need robust data confirming that the metabolic benefits outweigh this potential downside
Narrow Therapeutic Index Drugs: FDA Experience, Views, and Operations
If this fails, block submission because ambiguous answers prevent correct adjudication and downstream conditional requirements